RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.
Frontiers In Cellular And Infection Microbiology
Healer, Julie J; Thompson, Jennifer K JK; Mackwell, Karen L KL; Browne, Cecille D CD; Seager, Benjamin A BA; Ngo, Anna A; Lowes, Kym N KN; Silk, Sarah E SE; Pulido, David D; King, Lloyd D W LDW; Christen, Jayne M JM; Noe, Amy R AR; Kotraiah, Vinayaka V; Masendycz, Paul J PJ; Rajagopalan, Rajkannan R; Lucas, Leanne L; Stanford, Marianne M MM; Soisson, Lorraine L; Diggs, Carter C; Miller, Robin R; Youll, Susan S; Wycherley, Kaye K; Draper, Simon J SJ; Cowman, Alan F AF
Zhang, Hui H; Lin, Moubin M; Dong, Chao C; Tang, Yang Y; An, Liwei L; Ju, Junyi J; Wen, Fuping F; Chen, Fan F; Wang, Meng M; Wang, Wenjia W; Chen, Min M; Zhao, Yun Y; Li, Jixi J; Hou, Steven X SX; Lin, Xinhua X; Hu, Lulu L; Bu, Wenbo W; Wu, Dianqing D; Li, Lin L; Jiao, Shi S; Zhou, Zhaocai Z